Government summit board recommends against prescribing ‘Refresh Tears’ dry eye medication – The New Indian Express

By PTI

NEW DELHI: A top board from the Central Medicines Regulatory Authority has recommended scrapping the requirement for a prescription to buy Refresh Tears, a medicine for dry eyes.

Allergan India Pvt Ltd had contacted the Drugs Technical Advisory Board (DTAB) with representation on the matter so that the drug could be purchased without a prescription.

She maintained that “Refresh Tears,” which contains sodium carboxymethylcellulose eye drops in 0.5% w/v sterile ophthalmic solution, is intended to temporarily relieve burning, irritation and discomfort due to dry eyes. or exposure to wind or sun and can be used as a protector against further irritation.

“The Board, after detailed deliberation, has agreed to remove the requirement for a prescription from a licensed medical practitioner with respect to the pharmaceutical product ‘Refresh Tears’ for sale at retail. Accordingly, the relevant provisions of the Rules may be changed,” according to the minutes of a meeting held recently.

The DTAB recommendations are consistent with suggestions from the Central Drugs Standard Control Organization’s (CDSCO) Subject Matter Expert Committee (Ophthalmology) that the eye drops can be sold at retail without a prescription.

Allergan India Pvt Ltd had requested a change in the category of this product from prescription drug to non-prescription drug category.

Therefore, he requested an exemption from the affixing of the “Warning: For retail sale only on the prescription of a licensed physician” on the labels and packaging.

Refresh Tears Eye Drop is an eye lubricant used to relieve dry eyes that can occur if there are not enough tears produced naturally to keep the eye lubricated.

NEW DELHI: A top board from the Central Medicines Regulatory Authority has recommended scrapping the requirement for a prescription to buy Refresh Tears, a medicine for dry eyes. Allergan India Pvt Ltd had contacted the Drugs Technical Advisory Board (DTAB) with representation on the matter so that the drug could be purchased without a prescription. She maintained that “Refresh Tears,” which contains sodium carboxymethylcellulose eye drops in 0.5% w/v sterile ophthalmic solution, is intended to temporarily relieve burning, irritation and discomfort due to dry eyes. or exposure to wind or sun and can be used as a protector against further irritation. “The Board, after detailed deliberation, has agreed to remove the requirement for a prescription from a licensed medical practitioner with respect to the pharmaceutical product ‘Refresh Tears’ for sale at retail. Accordingly, the relevant provisions of the Rules may be changed,” according to the minutes of a meeting held recently. The DTAB recommendations are consistent with suggestions from the Central Drugs Standard Control Organization’s (CDSCO) Subject Matter Expert Committee (Ophthalmology) that the eye drops can be sold at retail without a prescription. Allergan India Pvt Ltd had requested a change in the category of this product from prescription drug to non-prescription drug category. Therefore, he requested a waiver of the affixing of the “Warning: For retail sale only on the prescription of a licensed physician” on the labels and packaging. Refresh Tears eye drops are an eye lubricant used to relieve dry eyes that can occur if there are not enough tears produced naturally to keep the eye lubricated.

Source link

About Alex S. Crone

Check Also

Americans’ use of prescription sleeping pills drops dramatically

Research we monitor After rising sharply for several decades, Americans’ use of prescription sleep aids …